Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study

Yıl: 2023 Cilt: 53 Sayı: 3 Sayfa Aralığı: 780 - 790 Metin Dili: İngilizce DOI: 10.55730/1300-0144.5641 İndeks Tarihi: 02-08-2023

Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study

Öz:
Background/aim: To have country-wide information about multidrug resistance (MDR) in isolates from community-acquired urinary tract infections (CAUTI) of Turkey, in terms of resistance rates and useful options. Materials and methods: We used a geocode standard, nomenclature of territorial units for statistics (NUTS), and a total of 1588 community-acquired isolates of 20 centres from 12 different NUTS regions between March 2019 and March 2020 were analysed. Results: Of the 1588 culture growths, 1269 (79. 9%) were Escherichia coli and 152 (9.6%) were Klebsiella spp. Male sex, advanced age, and having two or more risk factors showed a statistically significant relation with MDR existence (p < 0.001, p: 0.014, p < 0.001, respectively) that increasing number of risk factors or degree of advancing in age directly affects the number of antibiotic groups detected to have resistance by pathogens. In total, MDR isolates corresponded to 36.1% of our CAUTI samples; MDR existence was 35.7% in E. coli isolates and 57.2% in Klebsiella spp. isolates. Our results did not show an association between resistance or MDR occurrence rates and NUTS regions. Conclusion: The necessity of urine culture in outpatient clinics should be taken into consideration, at least after evaluating risk factors for antibacterial resistance individually. Community-acquired UTIs should be followed up time- and region-dependently. Antibiotic stewardship programmes should be more widely and effectively administrated.
Anahtar Kelime: Community-acquired infection urinary tract infections multidrug resistance quinolone resistance

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Foxman B. The epidemiology of urinary tract infection. Nature Reviews Urology 2010; 7 (12): 653-660. https://doi.org/10.1038/ nrurol.2010.190
  • 2. Lee DS, Lee SJ, Choe HS. Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. Biomed Research International 2018; 2018: 7656752. https://doi.org/10.1155/2018/7656752
  • 3. Wright SW, Wrenn KD, Haynes ML. Trimethoprim- sulfamethoxazole resistance among urinary coliform isolates. Journal of General Internal Medicine 1999; 14 (10): 606-609. https://doi.org/10.1046/j.1525-1497.1999.10128.x
  • 4. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases 2011; 52 (5): e103-120. https://doi. org/10.1093/cid/ciq257
  • 5. Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Medical Clinics of North America 1991; 75 (2): 313-325. https://doi.org/10.1016/s0025-7125(16)30456-4
  • 6. 6.Sobel JD, Brown P. Urinary Tract Infections. In: Bennett JE, Dolin R, Blaser MJ (editors). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases.9th ed. Philadelphia, PA, USA: Elsevier;2020. pp. 962-972.
  • 7. Collins AS. Preventing Health Care–Associated Infections. In: Hughes RG (editor). Patient Safety and Quality: An Evidence- Based Handbook for Nurses. Rockville (MD), Agency for Healthcare Research and Quality (US); 2008. pp. 2-547-575.
  • 8. Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections- an overview. Infection and Drug Resistance 2018; 11: 2321-2333. https://doi.org/
  • 9. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 2012; 18 (3): 268-281. https://doi. org/10.1111/j.1469-0691.2011.03570.x
  • 10. Kurutepe S, Sürücüoğlu S, Sezgin C, Gazi H, Gülay M et al. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Japanese Journal of Infectious Diseases 2005; 58 (3): 159-161.
  • 11. Arslan H, Azap ÖK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community- acquired urinary tract infections in Turkey. Journal of Antimicrobial Chemotherapy 2005; 56 (5): 914-918. https://doi. org/10.1093/jac/dki344
  • 12. Güçlü E, Halis F, Köse E, Öğütlü A, Karabay O. Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections. African Health Sciences 2021; 21 (1): 214-219. https://doi.org/10.4314/ahs.v21i1.28
  • 13. Köksal I, Yılmaz G, Ünal S, Zarakolu P, Korten V et al. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. Journal of Antimicrobial Chemotherapy 2017; 72 (5): 1364-1372. https:// doi.org/10.1093/jac/dkw574
  • 14. İşli F, Aksoy M, Aydıngöz SE. Rational Use of Antibiotics by Family Physicians in Turkey During Primary Healthcare Service: A Cross-Sectional Analysis Through The Prescription Information System. Turkish Journal of Family Medicine and Primary Care 2020; 14 (1): 87-95 (in Turkish with an abstract in English). https://doi.org/10.21763/tjfmpc.618125
  • 15. Demir T, Büyükgüçlü T. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. International Journal of Infectious Diseases 2013; 17 (11): 966-970. https://doi. org/10.1016/j.ijid.2013.04.005
  • 16. Barry MS, Diallo BA, Kanté D, Diallo IS. Antimicrobial susceptibility profile of community-acquired urinary tract infection in adults: A seven months’ prospective cross-sectional study in Dakar Town, Senegal. African Journal of Urology 2017; 23 (2): 166-171. https://doi.org/10.1016/j.afju.2016.11.005
  • 17. Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgraduate Medicine 2017; 129 (2): 242-258. https://doi.org/ 10.1080/00325481.2017.1246055
  • 18. Mulder M, Kiefte-de Jong JC, Goessens WH, de Visser H, Hofman A et al. Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population. Journal of Antimicrobial Chemotherapy 2017; 72 (1): 281-289. https://doi.org/10.11093/ jac/dkw399
  • 19. Stapleton AE, Wagenlehner FME, Mulgirigama A, Twynholm M. Escherichia coli Resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection in women: a systematic review. Antimicrobial Agents and Chemotherapy 2021; 64 (10): e00862-20. https://doi. org/10.1128/AAC.00862-20
  • 20. Caskurlu H, Culpan M, Erol B, Turan T, Vahaboglu H et al. Changes in antimicrobial resistance of urinary tract infections in adult patients over a 5-year period. Urologia Internationalis 2020; 104 (3-4): 287-292. https://doi.org/10.1159/000504415
  • 21. Parlak E, Çayır Y, Ertürk A. Rational antibiotic use among family physicians: a cross-sectional study from Erzurum. Eurasian Journal of Family Medicine 2013; 2 (1): 27-32 (In Turkish).
  • 22. Öztürk İİ, Avcı İY, Coşkun Ö. Prescription attitudes of general practioners at first stage health organizations in frequently diagnosed community-acquired infections and factors affecting these attitudes. Fırat Tıp Dergisi 2008; 13 (4): 255-260 (in Turkish with an abstract in English).
  • 23. Molahaliloğlu S, Alkan A, Dönertaş B. Assessment of the antibiotics in out-patient prescriptions with a diagnosis of a single infection. Marmara Pharmaceutical Journal 2012; 16 (3): 206-212 (In Turkish).
  • 24. Akıcı A, Güneysel Ö, Eroğlu S. Quinolone utilization in elderly at emergency service and evaluation of adverse events of quinolones. Akademik Açık Tıp Dergisi 2008; 7 (1): 24-28 (In Turkish).
  • 25. Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Archives of Internal Medicine 2002; 162 (1): 41-47. https://doi.org/10.1001/archinte.162.1.41
  • 26. Karlowsky JA, Hoban DJ, Decorby MR, Laing NM, Zhanel GG. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrobial Agents and Chemotherapy 2006; 50 (6): 2251-2254. https://doi. org/10.1128/AAC.00123-06
  • 27. Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J et al. An evaluation of multidrug- resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Annals of Clinical Microbiology and Antimicrobials 2018; 17 (1): 34. https://doi.org/10.1186/s12941-018-0286-5
APA Sencan İ, KARABAY O, altay f, Suzuk Yıldız S, Şimşek H, Gözükara M, Kuzi S, ESER KARLIDAG G, Kaya S, kul g, Türkoğlu Yılmaz E, ergut sezer b, Korkmaz N, Yıldız Kaya S, SAYAR M, Bulut D, akgul f, Cag Y, Agalar C, Bestepe Dursun Z, Tasbakan m, Aydemir S, Seyman D, YILDIRIM M, habip z, altın n, Uzar H, Bektaş B, Öztürk Engin D, Erdem H, Sürme S (2023). Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. , 780 - 790. 10.55730/1300-0144.5641
Chicago Sencan İrfan,KARABAY OĞUZ,altay fatma aybala,Suzuk Yıldız Serap,Şimşek Hüsniye,Gözükara Melih Gaffar,Kuzi Semanur,ESER KARLIDAG Gulden,Kaya Safak,kul gülnur,Türkoğlu Yılmaz Emine,ergut sezer busra,Korkmaz Nesibe,Yıldız Kaya Sibel,SAYAR MERVE SEFA,Bulut Dilek,akgul fethiye,Cag Yasemin,Agalar Canan,Bestepe Dursun Zehra,Tasbakan meltem,Aydemir Sohret,Seyman Derya,YILDIRIM Mustafa,habip zafer,altın nilgün,Uzar Hanife,Bektaş Begüm,Öztürk Engin Derya,Erdem Huseyin Aytac,Sürme Serkan Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. (2023): 780 - 790. 10.55730/1300-0144.5641
MLA Sencan İrfan,KARABAY OĞUZ,altay fatma aybala,Suzuk Yıldız Serap,Şimşek Hüsniye,Gözükara Melih Gaffar,Kuzi Semanur,ESER KARLIDAG Gulden,Kaya Safak,kul gülnur,Türkoğlu Yılmaz Emine,ergut sezer busra,Korkmaz Nesibe,Yıldız Kaya Sibel,SAYAR MERVE SEFA,Bulut Dilek,akgul fethiye,Cag Yasemin,Agalar Canan,Bestepe Dursun Zehra,Tasbakan meltem,Aydemir Sohret,Seyman Derya,YILDIRIM Mustafa,habip zafer,altın nilgün,Uzar Hanife,Bektaş Begüm,Öztürk Engin Derya,Erdem Huseyin Aytac,Sürme Serkan Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. , 2023, ss.780 - 790. 10.55730/1300-0144.5641
AMA Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. . 2023; 780 - 790. 10.55730/1300-0144.5641
Vancouver Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. . 2023; 780 - 790. 10.55730/1300-0144.5641
IEEE Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S "Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study." , ss.780 - 790, 2023. 10.55730/1300-0144.5641
ISNAD Sencan, İrfan vd. "Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study". (2023), 780-790. https://doi.org/10.55730/1300-0144.5641
APA Sencan İ, KARABAY O, altay f, Suzuk Yıldız S, Şimşek H, Gözükara M, Kuzi S, ESER KARLIDAG G, Kaya S, kul g, Türkoğlu Yılmaz E, ergut sezer b, Korkmaz N, Yıldız Kaya S, SAYAR M, Bulut D, akgul f, Cag Y, Agalar C, Bestepe Dursun Z, Tasbakan m, Aydemir S, Seyman D, YILDIRIM M, habip z, altın n, Uzar H, Bektaş B, Öztürk Engin D, Erdem H, Sürme S (2023). Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turkish Journal of Medical Sciences, 53(3), 780 - 790. 10.55730/1300-0144.5641
Chicago Sencan İrfan,KARABAY OĞUZ,altay fatma aybala,Suzuk Yıldız Serap,Şimşek Hüsniye,Gözükara Melih Gaffar,Kuzi Semanur,ESER KARLIDAG Gulden,Kaya Safak,kul gülnur,Türkoğlu Yılmaz Emine,ergut sezer busra,Korkmaz Nesibe,Yıldız Kaya Sibel,SAYAR MERVE SEFA,Bulut Dilek,akgul fethiye,Cag Yasemin,Agalar Canan,Bestepe Dursun Zehra,Tasbakan meltem,Aydemir Sohret,Seyman Derya,YILDIRIM Mustafa,habip zafer,altın nilgün,Uzar Hanife,Bektaş Begüm,Öztürk Engin Derya,Erdem Huseyin Aytac,Sürme Serkan Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turkish Journal of Medical Sciences 53, no.3 (2023): 780 - 790. 10.55730/1300-0144.5641
MLA Sencan İrfan,KARABAY OĞUZ,altay fatma aybala,Suzuk Yıldız Serap,Şimşek Hüsniye,Gözükara Melih Gaffar,Kuzi Semanur,ESER KARLIDAG Gulden,Kaya Safak,kul gülnur,Türkoğlu Yılmaz Emine,ergut sezer busra,Korkmaz Nesibe,Yıldız Kaya Sibel,SAYAR MERVE SEFA,Bulut Dilek,akgul fethiye,Cag Yasemin,Agalar Canan,Bestepe Dursun Zehra,Tasbakan meltem,Aydemir Sohret,Seyman Derya,YILDIRIM Mustafa,habip zafer,altın nilgün,Uzar Hanife,Bektaş Begüm,Öztürk Engin Derya,Erdem Huseyin Aytac,Sürme Serkan Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turkish Journal of Medical Sciences, vol.53, no.3, 2023, ss.780 - 790. 10.55730/1300-0144.5641
AMA Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turkish Journal of Medical Sciences. 2023; 53(3): 780 - 790. 10.55730/1300-0144.5641
Vancouver Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study. Turkish Journal of Medical Sciences. 2023; 53(3): 780 - 790. 10.55730/1300-0144.5641
IEEE Sencan İ,KARABAY O,altay f,Suzuk Yıldız S,Şimşek H,Gözükara M,Kuzi S,ESER KARLIDAG G,Kaya S,kul g,Türkoğlu Yılmaz E,ergut sezer b,Korkmaz N,Yıldız Kaya S,SAYAR M,Bulut D,akgul f,Cag Y,Agalar C,Bestepe Dursun Z,Tasbakan m,Aydemir S,Seyman D,YILDIRIM M,habip z,altın n,Uzar H,Bektaş B,Öztürk Engin D,Erdem H,Sürme S "Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study." Turkish Journal of Medical Sciences, 53, ss.780 - 790, 2023. 10.55730/1300-0144.5641
ISNAD Sencan, İrfan vd. "Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational study". Turkish Journal of Medical Sciences 53/3 (2023), 780-790. https://doi.org/10.55730/1300-0144.5641